PR NEWSWIRE - Contenuti promozionali

immediapress comunicato stampa

OCI N.V. Notes Enterprise Chamber Decision Not to Order Inquiry

AMSTERDAM, Oct. 7, 2026 /PRNewswire/ -- OCI N.V. ("OCI" or the "Company") (Euronext: OCI) notes that the Enterprise Chamber of the Amsterdam Court of Appeal has today dismissed the petition brought by VEB and certain other shareholders and declined to order an inquiry into OCI's policy and course of ...

immediapress comunicato stampa

SEVER LIFE SCIENCES B.V. THROUGH ITS SUBSIDIARY NORDIC PHARMA, INC. (U.S.), TO SHARE PATIENT DATA AND PATIENT EXPERIENCE STUDY FOR LACRIFILL® CANALICULAR GEL, A NOVEL THERAPY FOR OCULAR SURFACE CONTROL, DURING AMERICAN ACADEMY OF OPHTHALMOLOGY (AAO) 2026

DOYLESTOWN, Pa., Oct. 7, 2026 /PRNewswire/ -- Nordic Pharma, Inc., a subsidiary of SEVER Life Sciences B.V., will feature LACRIFILL® Canalicular Gel, a novel therapy for ocular surface control, during the American Academy of Ophthalmology Annual Meeting in New Orleans, LA, from October 9–12 and will ...



SEGUICI SUI SOCIAL

threads whatsapp linkedin twitter youtube facebook instagram

ora in
Prima pagina
articoli
in Evidenza